Survival and number	1
olfactory ensheathing cells	24
spinal cord of rats LI Yue 李越 , YU Hua-lin 余化霖 *	77
spinal cord	77
rats LI Yue 李越 , YU Hua-lin 余化霖	92
rats LI Yue 李越	92
rats	92
LI Yue 李越	98
YU Hua-lin 余化霖	109
CHEN Li-fa 陈莉发 , DUAN Chao-xia 段朝霞 , ZHANG Jie-yuan 张洁元and LI Bing-cang 李兵仓	126
CHEN Li-fa 陈莉发	126
DUAN Chao-xia 段朝霞 , ZHANG Jie-yuan 张洁元and LI Bing-cang 李兵仓	142
DUAN Chao-xia 段朝霞 , ZHANG Jie-yuan 张洁元and LI Bing-cang	142
李兵仓	196
Abstract 】 Objective	203
the survival and the number	234
the survival	234
the number	251
olfactory ensheathing cells -LRB- OECs -RRB-	265
olfactory ensheathing cells	265
OECs	294
the	316
spinal cord	329
a basis	359
further studying the biological action of OECs	371
further	371
the biological action of OECs	388
the biological action	388
OECs	413
Methods	419
The rat	428
spinal cords	436
NYU-impactor II at T10 level	468
NYU-impactor II	468
T10 level	487
a 10 g rod	509
a height of 25 mm	525
a height	525
25 mm	537
the 1st week after injury	547
the 1st week	547
injury	566
OECs isolated freshly from green fluorecense protein -LRB- GFP -RRB- of the rats	574
OECs	574
green fluorecense protein -LRB- GFP -RRB- of the rats	601
green fluorecense protein -LRB- GFP -RRB-	601
green fluorecense protein	601
GFP	628
the rats	636
the spinal cord	668
injured site	687
two sites	710
1 mm	720
the caudal and rostral ends with the OECs number of 30000/μl × 3 =	736
the caudal and rostral ends	736
the OECs number of 30000/μl × 3 =	769
the OECs number	769
30000/μl × 3 =	788
30000/μl ×	788
90000	800
The survival and the number of OECs	807
The survival	807
the number of OECs	824
the number	824
OECs	838
the fluorescense microscope	901
1 week to 13 weeks	934
1 week	934
13 weeks	944
transplantation	959
The motor function of the cord	976
The motor function	976
the cord	998
BBB score	1026
Results	1037
GFP-OECs	1046
13 weeks	1082
the contused spinal cord	1098
the	1098
spinal cord	1111
Their arrangement	1124
their number	1170
1 week to 13 weeks	1202
1 week	1202
13 weeks	1212
injury	1227
The average number of GFP-OECs	1235
The average number	1235
GFP-OECs	1257
536	1270
the 1st week	1277
less than 1 % of the number as	1301
less than 1 %	1301
the number as	1317
original transplantation	1345
then	1377
the number of GFP-OECs	1383
the number	1383
GFP-OECs	1397
the most obvious decrease	1437
1	1480
week	1482
2 weeks	1490
The extent of decrease at other time points	1499
The extent	1499
decrease at other time points	1513
decrease	1513
other time points	1525
contrast to the cell number	1567
contrast	1567
the cell number	1579
motor function of the cord	1596
motor function	1596
the cord	1614
transplantation	1653
Conclusions	1670
The survival and the number of GFPOECs	1683
The survival	1683
the number of GFPOECs	1700
the number	1700
GFPOECs	1714
the animals	1744
the pathological reaction of the host cord	1776
the pathological reaction	1776
the host cord	1805
it	1825
the motor function recovery of the contused cord	1842
the motor function recovery	1842
the contused cord	1873
the	1873
cord	1886
Olfactory ensheathing cells -LRB- OECs -RRB-	1893
Olfactory ensheathing cells	1893
OECs	1922
the characteristics of the astrocyte , oligodentrocyte and Schwann cells ,1	1942
the characteristics	1942
the astrocyte , oligodentrocyte and Schwann cells ,1	1965
the astrocyte	1965
oligodentrocyte and Schwann cells ,1	1980
oligodentrocyte and Schwann cells	1980
,1	2013
neuronotrophic factors	2037
nerve growth factor -LRB- NGF -RRB-	2068
nerve growth factor	2068
NGF	2089
brain-derived neurotrophic factor -LRB- BDNF -RRB-	2095
brain-derived neurotrophic factor	2095
BDNF	2130
glia cell line-derived neurotrophic factor -LRB- GDNF -RRB-	2137
glia cell	2137
line-derived neurotrophic factor -LRB- GDNF -RRB-	2147
line-derived neurotrophic factor	2147
GDNF	2181
neurotrophin 4/5 -LRB- NT-4 / 5 -RRB- , neureglin -LRB- NRG -RRB-	2188
neurotrophin 4/5 -LRB- NT-4 / 5 -RRB- , neureglin	2188
neurotrophin 4/5	2188
NT-4	2206
neureglin	2215
NRG	2226
etc2	2232
some substances	2241
L1 , neural cell adhesion molecule , and laminin3	2265
L1	2265
neural cell adhesion molecule	2269
laminin3	2304
nerve growth and regeneration	2336
OECs	2377
various kinds of acute or chronic animal spinal cord injuries -LRB- SCI -RRB-	2400
various kinds	2400
acute or chronic animal spinal cord injuries -LRB- SCI -RRB-	2417
acute or chronic animal spinal cord injuries	2417
SCI	2463
transection and contusion4-9 as well as human spinal cord injuries10-12	2478
transection and contusion4-9	2478
human spinal cord injuries10-12	2518
Huang et al13	2551
Huang	2551
et al13	2557
the therapeutic effect of OECs transplantation	2583
the therapeutic effect	2583
OECs transplantation	2609
656 cases of advanced spinal cord injuries	2633
656 cases	2633
advanced spinal cord injuries	2646
457cases of amyotrophic lateral sclerosis	2677
457cases	2677
amyotrophic lateral sclerosis	2689
68 cases of cerebral palsy	2720
68 cases	2720
cerebral palsy	2732
20 cases of multiple sclerosis	2748
20 cases	2748
multiple sclerosis	2760
11 cases of cerebrovascular sequelae ,10 cases of ataxia and so on	2780
11 cases	2780
cerebrovascular sequelae ,10 cases of ataxia and so on	2792
cerebrovascular sequelae	2792
,10 cases of ataxia	2816
,10 cases	2816
ataxia	2829
1 255 cases	2852
total of nerve injuries and diseases	2867
total	2867
nerve injuries and diseases	2876
the basic and clinical studies	2909
the recovery of the structure and function	2954
the recovery	2954
the structure and function	2970
spinal cord injuries	3003
little attention	3025
the main body of treatment , e.g. changes of OECs	3053
the main body of treatment , e.g.	3053
the main body	3053
treatment	3070
changes of OECs	3086
changes	3086
OECs	3097
transplantation	3108
basic evidence	3148
the aspect of donor	3168
the aspect	3168
donor	3182
OECs application in the treatment of SCI	3192
OECs application	3192
the treatment of SCI	3212
the treatment	3212
SCI	3229
we	3234
the survival and number of OECs within 13 weeks	3245
the survival and number	3245
OECs within 13 weeks	3272
OECs	3272
13 weeks	3284
the green fluorescence protein	3310
GFP	3342
OECs into the contused spinal cord of rats	3347
OECs	3347
the contused spinal cord of rats	3357
the	3357
spinal cord of rats	3370
spinal cord	3370
rats	3385
METHODS Spinal cord contusion The rats	3392
METHODS Spinal cord contusion	3392
METHODS	3392
Spinal cord contusion	3400
The rats	3422
the approval	3458
the Animal Care and Ethics Committee	3474
the Third Military Medical University , Chongqing , China	3514
the Third Military Medical University	3514
Chongqing , China	3553
The SD	3571
adult rats	3578
350-400 g	3598
an intraperitioneal injection	3631
pentobarbital sodium -LRB- 30 mg / kg -RRB- and incision	3664
pentobarbital sodium -LRB- 30 mg / kg -RRB-	3664
pentobarbital sodium	3664
30 mg	3686
kg	3693
incision	3701
routine asepsis	3725
the vertebral lamina of T10 spine	3742
the vertebral lamina	3742
T10 spine	3766
the spinal cord	3799
NYU-impactor II	3833
a 10 g rod	3861
a height of 25 mm.Postoperative care	3877
a height	3877
25 mm.Postoperative care	3889
cleaning , nutrition , infection prevention and artificial urination	3923
cleaning	3923
nutrition	3933
infection prevention	3944
artificial urination	3969
Donor cell preparation The GFP transgenic rats weighing 220 g around	3991
Donor cell preparation The GFP transgenic rats	3991
Donor cell preparation The GFP	3991
Donor cell preparation	3991
The GFP	4014
220 g	4047
pentobarbitone	4091
decapitation	4120
The head	4134
the 0.5 % iodine solution	4161
3 minutes	4198
95 % alcohol for deiodination	4231
95 % alcohol	4231
deiodination	4247
The skull	4261
olfactory nerves	4283
olfactory bulbs	4310
their caudal parts	4346
The remaining head parts	4379
the 4 °C precooling D-Hanks solution	4423
4 °C precooling D-Hanks	4427
penicillin 100 U/L , streptomycin100 μg/ml	4471
penicillin 100 U/L	4471
streptomycin100 μg/ml	4491
a microscope	4521
the piamater and its adhesive vessels	4535
the piamater	4535
its adhesive vessels	4552
the bulbs	4587
longitudinal axis	4615
the internal white matter	4637
The remaining grey matter	4676
4 °C precooling D-Hanks	4718
solution for 3 times , then	4741
solution	4741
3 times , then	4754
3 times	4754
1 mm	4777
× 1 mm × 1 mm explants	4781
× 1 mm ×	4781
1 mm explants	4787
0.125 %	4819
trypsin	4826
20 minutes at 37 °C	4838
20 minutes	4838
37 °C	4852
The digestion	4858
DFF20 -LRB- DMEM/F12 / 20 % FCS -RRB- for 5 minutes	4887
DFF20 -LRB- DMEM/F12 / 20 % FCS -RRB-	4887
DFF20	4887
DMEM/F12	4894
20 % FCS	4904
20 %	4904
FCS	4907
5 minutes	4916
The explants	4927
unicellular suspension	4956
a pipette	4984
placed for 5 minutes	5001
5	5012
the upper suspension	5023
the poly-L-lysine -LRB- 10 μg/ml -RRB-	5078
the poly-L-lysine	5078
10 μg/ml	5097
coated culture plate	5107
an incubator at 37 °C	5144
an incubator	5144
37 °C	5160
5 % CO2 for 3 days	5166
5 % CO2	5166
3 days	5176
half volume of medium	5200
half volume	5200
medium	5215
medium	5241
Forskolin -LRB- 100 mg/L -RRB-	5259
Forskolin	5259
100 mg/L	5270
basic fibroblast growth factor -LRB- bFGF , 0.01 mg/L -RRB-	5284
basic fibroblast growth factor	5284
bFGF , 0.01 mg/L	5316
bFGF	5316
0.01 mg/L	5322
The total volume of medium	5334
The total volume	5334
medium	5354
every 2-3 days	5375
the next 14 days	5397
NGFRp75	5415
S-100 double immunofluorescent staining	5424
Hoechst 33342 nuclear labeling	5468
Hoechst 33342	5468
nuclear labeling	5482
identification and purity detection of OECs -LRB- Figure 1 -RRB-	5513
identification and purity detection	5513
OECs -LRB- Figure 1 -RRB-	5552
OECs	5552
Figure 1	5558
The OECs cultured for 10 days	5569
The OECs	5569
10 days	5591
immunofluorescence cytochemistry staining	5613
the method	5660
The cultured OECs	5707
The	5707
OECs	5720
4 % parafornaldehyde for 15 minutes for 2 times	5741
4 % parafornaldehyde	5741
15 minutes for 2 times	5765
15 minutes	5765
2 times	5780
normal goat serum for 30 minutes at room temperature	5804
normal goat serum	5804
30 minutes at room temperature	5826
30 minutes	5826
room temperature	5840
primary antibody working solution	5874
Mouse anti-S-100 , rabbit anti-nerve growth factor recptor p75 , 1:100	5909
Mouse anti-S-100	5909
rabbit anti-nerve growth factor recptor p75	5927
rabbit anti-nerve growth	5927
factor recptor p75	5952
1:100	5972
a 4 °C refrigerator	5992
OECs	6026
secondary antibody working solution	6049
i.e. tetramethylrhodamine isothiocyanate	6085
goat anti-rabbit lgG	6135
fluorescein isothiocyanate -LRB- FITC -RRB-	6157
fluorescein isothiocyanate	6157
FITC	6185
goat anti-mouse lgG	6200
,1 : 50 , cultured for 1 hour away from light ,	6219
,1 : 50	6219
1 hour	6239
light	6256
5 μg/ml	6280
Hoechst 33342 working solution cultured for 30 minutes away from light	6288
Hoechst 33342	6288
solution cultured for 30 minutes away from light	6310
solution	6310
30 minutes	6332
light	6353
The 0.001 mol/L phosphate buffer	6360
substitution for primary antibody in control group	6405
substitution	6405
primary antibody in control group	6422
primary antibody	6422
control group	6442
we	6484
fluorescence microscope	6492
observation	6520
different emission	6535
The cell purity	6555
the average	6591
the ratio of NGFRp75	6606
the ratio	6606
NGFRp75	6619
S-100 double positive cells number/Hoechst positive cells number	6631
S-100 double positive cells number/Hoechst	6631
positive cells number	6674
The OECs purity	6697
95 % in our experiment	6722
95 %	6722
our experiment	6729
Donor cell transplantation	6745
Seven days	6772
spinal cord contusion	6789
the contused spinal cords	6812
the	6812
spinal cords	6825
The brain	6858
solid positioner	6868
the rats and 1 μl OECs suspension	6901
30000/μl	6936
the injury site and other two sites	6964
the injury site	6964
two sites	6990
1 mm	7000
the caudal and rostral ends of the spinal cord with a glass microelectrode	7016
the caudal and rostral ends	7016
the spinal cord with a glass microelectrode	7047
the spinal cord	7047
a glass microelectrode	7068
a dissection microscope	7097
The injection depth	7122
0.8 mm	7146
the speed	7157
1 μl/min	7171
The needle	7181
2 minutes after injection	7213
2 minutes	7213
injection	7229
The same method	7240
the control group	7268
OECs	7291
DMEM.The rats	7318
the same protocol	7354
experimental group	7375
awakening	7399
Histologic analysis	7410
1 , 2 , 3 , 4 , 8 , and 13 weeks after transplantation	7433
1	7433
2	7436
3	7439
4	7442
8	7445
13 weeks after transplantation	7452
13 weeks	7452
transplantation	7467
the rats	7484
their thoracic cavities	7516
The rats	7553
saline via the left ventricle	7581
saline	7581
the left ventricle	7592
the effluent fluid	7617
200 ml of 4 % paraformaldehyde	7681
200 ml	7681
4 % paraformaldehyde	7691
The cords of 1 cm in length at the transplanted rostral and caudal sites	7712
The cords	7712
1 cm in length at the transplanted rostral and caudal sites	7725
1 cm	7725
length at the transplanted rostral and caudal sites	7733
length	7733
the transplanted rostral and caudal sites	7743
the transplanted rostral	7743
caudal sites	7772
the same stationary liquid	7816
4 hours	7859
trans	7872
the 20 % cane sugar solution overnight	7890
the 20 % cane sugar solution	7890
overnight	7918
The icy slicker -LRB- Leica CM 1900 , Germany -RRB-	7929
The icy slicker	7929
Leica CM	7946
1900 , Germany	7955
1900	7955
Germany	7961
the spinal cords	7988
20 μm thick sections	8010
the longitudinal axis of spinal cord	8037
the longitudinal axis	8037
spinal cord	8062
Sixty rats	8075
the 6 time points	8099
10 rats in each including 5 rats in experimental group and 5 in control group	8122
10 rats	8122
each including 5 rats in experimental group and 5 in control group	8133
each	8133
5 rats in experimental group and 5 in control group	8148
5 rats in experimental group	8148
5 rats	8148
experimental group	8158
5 in control group	8181
5	8181
control group	8186
Semi-quantitative analysis of donor cells All the sequential sections	8201
Semi-quantitative analysis	8201
donor cells All the sequential sections	8231
donor cells	8231
All the sequential sections	8243
fluorescence microscope -LRB- Olympus BX50 , Japan -RRB-	8304
fluorescence microscope	8304
Olympus BX50	8329
Japan	8343
GFP-OECs and autofluorescence host cells	8350
FITC and Rodamine excitation	8413
The sections	8456
the most	8480
OECs at each time point	8489
OECs	8489
each time point	8497
microscope and continuous digital photos	8546
charge	8614
CCD	8637
digital camera -LRB- Olympus DP71 , Japan -RRB-	8642
digital camera	8642
Olympus DP71	8658
Japan	8672
the software condition of 10 × and 20	8686
the software condition	8686
10 × and 20	8712
10 ×	8712
20	8720
The number of the cells	8725
The number	8725
the cells	8739
the survival number of OECs at different time point	8778
the survival number	8778
OECs at different time point	8801
OECs	8801
different time point	8809
transplantation	8836
Motor function assessment The extent of recovery of motor function in host rats	8853
Motor	8853
function assessment	8859
The extent of recovery of motor function in host rats	8879
The extent	8879
recovery of motor function in host rats	8893
recovery	8893
motor function in host rats	8905
motor function	8905
host rats	8923
the BBB scale	8949
a doubleblind and double-observer method	8968
The scores from the two observers	9010
The scores	9010
the two observers	9026
The assessment	9059
the 1st week	9085
transplantation	9104
a week	9139
the 13th week	9151
Statistical analysis	9166
The data of semi-quantitative measurement	9187
The data	9187
semi-quantitative measurement	9199
SPSS version	9246
12.0 software and the results	9259
12.0 software	9259
the results	9277
mean ± standard deviation -LRB- χ ± s -RRB-	9309
mean ± standard deviation	9309
χ ± s	9336
χ	9336
± s	9338
Turkey Test of One-Way ANOVA	9344
Turkey Test	9344
One-Way ANOVA	9359
multiple-sample mean comparison	9386
significance	9423
P	9447
RESULTS Figure 1 .	9456
RESULTS	9456
Figure 1	9464
Identification of OECs	9474
Identification	9474
OECs	9492
Hoechst -LRB- A -RRB- , P75 -LRB- B -RRB- and S100 -LRB- C -RRB-	9508
Hoechst -LRB- A -RRB-	9508
Hoechst	9508
A	9517
P75 -LRB- B -RRB-	9521
P75	9521
B	9526
S100 -LRB- C -RRB-	9533
S100	9533
C	9539
D	9543
merged picture of A , B and C. × 200	9549
merged picture	9549
A , B and C. × 200	9567
A	9567
B	9570
C. × 200	9576
Figure 2 .	9586
Figure	9586
2	9593
Qualitative observation of the survival and number of OECs	9596
Qualitative observation	9596
the survival and number of OECs	9623
the survival and number	9623
OECs	9650
spinal cord of rats from the 1st week to 13th week	9667
spinal cord	9667
rats from the 1st week to 13th week	9682
rats	9682
the 1st week to 13th week	9692
the 1st week	9692
13th week	9708
transplantation	9724
Their arrangement	9741
their number	9787
1	9819
week	9821
13 weeks	9829
A , B , C , D , E , F	9839
B , C , D , E	9842
B	9842
C	9845
D	9848
E	9851
GFP-OECs at the 1st , 2nd , 3rd , 4th , 8th	9861
GFP-OECs	9861
the 1st , 2nd , 3rd , 4th , 8th	9873
13th week	9906
transplantation	9922
Scale	9939
100 μm	9949
Figure 3 .	9958
Figure	9958
3	9965
Semi-quantitative observation	9968
GFP-OECs from the 1st week to 13th week	10001
GFP-OECs	10001
the 1st week to 13th week	10015
the 1st week	10015
13th week	10031
transplantation	10047
+	10064
compared	10067
the 1st week , P < 0.05	10081
the 1st week	10081
P < 0.05	10095
P <	10095
P	10095
0.05	10097
+	10103
+	10104
compared	10107
the 1st week , P < 0.01	10121
the 1st week	10121
P < 0.01	10135
P <	10135
P	10135
0.01	10137
Figure 4 .	10144
Figure	10144
4	10151
The BBB scale of rats ' motor function .	10154
The BBB scale	10154
rats ' motor function	10171
rats '	10171
control group , P <	10210
control group	10210
P <	10225
P	10225
<	10226
0.05 ; ** : compared with control group , P < 0.01	10227
0.05	10227
control group , P < 0.01	10251
control group	10251
P < 0.01	10266
P <	10266
P	10266
0.01	10268
Qualitative observation The light green GFP-OECs	10275
Qualitative observation	10275
The light green GFP-OECs	10299
host 's spinal cord	10350
host 's	10350
They	10370
the grey matter along the long axis , spread	10402
the grey matter	10402
the long axis , spread	10424
the long axis	10424
spread	10439
the rostral and caudal sites	10459
the rostral	10459
caudal sites	10475
the early post-transplantation period -LRB- within 2 weeks -RRB-	10492
the early post-transplantation period	10492
2 weeks	10538
some OECs	10548
the host 's spinal cord independently	10569
the host 's spinal cord	10569
the host 's	10569
some interconnected as reticulate form	10611
the large number and the compact arrangement of OECs	10666
the large number	10666
the compact arrangement of OECs	10687
the compact arrangement	10687
OECs	10714
the distribution of OECs	10720
the distribution	10720
OECs	10740
conglom eration form under a low power microscope	10766
conglom eration form	10766
a low power microscope	10793
the migration , dispersion and decreasing amount of GFP-OECs	10828
the migration , dispersion and decreasing amount	10828
GFP-OECs	10879
the independently existing GFP-OECs	10889
and more OECs	10944
slender cell process	10981
the reticulate form	11005
Figure 2	11043
Semi-quantitative observation	11054
We	11084
the number of OECs	11095
the number	11095
OECs	11109
a microscope	11120
One week	11134
transplantation	11149
the OECs ' number of each section	11166
the OECs ' number	11166
the OECs '	11166
each section	11185
536	11207
132.74	11211
90 000 during transplantation	11233
90 000	11233
transplantation	11247
the surviving number	11264
less than 1 % of original one	11289
less than 1 %	11289
original one	11305
Two weeks	11319
transplantation	11335
the number	11352
greatly -LRB- 426 ± 124.14 -RRB-	11373
greatly	11373
426 ± 124.14	11382
426	11382
124.14	11386
the number	11409
the declining rate	11450
Thirteen weeks	11479
transplantation	11500
the number of each section	11516
the number	11516
each section	11530
321 ± 110.24	11555
Figure 2	11572
we	11581
the number	11597
a declining curve form from the 1st week to the 13th week	11624
a declining curve form	11624
the 1st week to the 13th week	11652
the 1st week	11652
the 13th week	11668
transplantation , in which the curve is more steep during 1 week to 2 weeks	11688
transplantation	11688
the curve	11714
1 week to 2 weeks	11745
1 week	11745
2 weeks	11755
statistical analysis	11768
there	11803
no difference between adjacent groups	11812
no difference	11812
adjacent groups	11834
the GFP-OECs number of another 5 time points	11860
the GFP-OECs number	11860
another 5 time points	11883
that of the 1st week time point	11910
that	11910
the 1st week time point	11918
the statistically significant difference	11943
the 3rd week	12002
transplantation -LRB- Figure 3 -RRB-	12021
transplantation	12021
Figure 3	12038
Motor function assessment The scale of the motor function in experimental group	12049
Motor	12049
function assessment	12055
The scale of the motor function in experimental group	12075
The scale	12075
the motor function in experimental group	12088
the motor function	12088
experimental group	12110
the 1st week	12140
The scale	12154
17.5	12196
the 13th week	12204
the rats ' surviving time	12221
the rats '	12221
the normal criterion	12275
The motor function in control group	12297
The motor function	12297
control group	12319
the rats ' surviving time extended but at a low level	12356
the rats ' surviving time	12356
the rats '	12356
a low level	12396
experimental group.There	12422
significant difference between the two groups	12451
significant difference	12451
the two groups	12482
each time	12500
point -LRB- Figure 4 -RRB-	12510
point	12510
Figure 4	12517
DISCUSSION	12529
The application of OECs to repair spinal cord injuries	12540
The application	12540
OECs to repair spinal cord injuries	12559
spinal cord injuries	12574
a hot topic that is paid continuous attention and OECs	12598
a hot topic	12598
continuous attention and OECs	12623
the only glia cells applied in clinic to date	12657
the only glia cells	12657
clinic	12688
date	12698
Previous animal experiments	12704
OECs	12746
the recovery	12763
the structure and function of injured spinal cord	12779
the structure and function	12779
injured spinal cord	12809
.14,15	12828
clinical application , the results of phase	12838
clinical application	12838
the results of phase	12860
the results	12860
phase	12875
I	12881
clinical trial	12883
OECs	12919
neuropathy aggravation .11	12954
The domestic results of 656 cases of advanced SCI treated with OECs	12980
The domestic results	12980
656 cases of advanced SCI	13004
656 cases	13004
advanced SCI	13017
OECs	13043
OECs	13058
the nerve function	13075
advanced spinal cord injuries	13097
aggravation .13	13138
the theory and applied research of OECs	13162
the theory	13162
applied research	13177
OECs	13197
certain achievements	13215
the general situation	13240
the basic research	13277
insufficient14	13305
the clinical application	13324
.16,17 Spinal contusion	13371
a classic spinal cord injury	13398
the survival status	13432
OECs transplanted into this kind of spinal cord injury	13461
OECs	13461
this kind of spinal cord injury	13484
this kind	13484
spinal cord injury	13497
the effect of clinical application	13538
the effect	13538
clinical application	13552
Our results	13574
the surviving number of OECs	13598
the surviving number	13598
OECs	13622
less than one percent	13631
transplanted number at the 1st week af ter transplantation	13656
transplanted number	13656
the 1st week af ter transplantation	13679
most OECs	13732
We	13748
the cause of death	13764
the cause	13764
death	13777
the new environment	13797
donor cells	13828
the death of donor cells caused by intense pathological reaction following SCI	13844
the death	13844
donor cells caused by intense pathological reaction following SCI	13857
donor cells	13857
intense pathological reaction following SCI	13879
intense pathological reaction	13879
SCI	13919
addition	13927
the factitious handling	13937
the process of detachment and purification of donor cells	13968
the process	13968
detachment and purification of donor cells	13983
detachment and purification	13983
donor cells	14014
another cause of cell death	14029
another cause	14029
cell death	14046
These results	14058
the artificial impact	14085
pathological reaction	14157
the local microenvironment should be paid more attention	14193
the local microenvironment	14193
more attention	14235
OECs	14274
SCI	14291
OECs	14305
host 's spinal cord	14321
host 's	14321
a very significant problem	14343
We	14371
the average number of GFP-OECs	14388
the average number	14388
GFP-OECs	14410
535 at the 1st week	14423
535	14423
the 1st week	14430
transplantation	14449
427	14488
the 2nd week	14495
The average number	14509
3-13 weeks	14564
the pathological reaction	14592
2 weeks	14644
transplantation	14658
the total number of donor cells	14686
the total number	14686
donor cells	14706
the whole	14739
the pathological reaction	14752
We	14788
OECs ' number	14816
OECs '	14816
there	14864
marked differences in the surviving number of OECs among individual rats	14875
marked differences	14875
the surviving number of OECs among individual rats	14897
the surviving number	14897
OECs among individual rats	14921
OECs	14921
individual rats	14932
the 13th week	14963
the mean number	14978
322	14998
the standard deviation	15006
to110	15040
the effective cells number	15063
rats after cell transplantation is different and so	15093
rats	15093
cell transplantation	15104
the effectiveness of treatment	15148
the effectiveness	15148
treatment	15169
Another interesting experimental phenomenon	15180
the function of injured spinal cord	15233
the function	15233
injured spinal cord	15249
the GFP-OECs number decreased after transplantation	15292
the GFP-OECs number	15292
transplantation	15328
It	15345
the cell transplantation	15360
spinal cord function recovery	15404
the function of experimental group and control group	15445
the function	15445
experimental group and control group	15461
the former 's function recovery	15499
the former 's	15499
the latter 's	15546
each time point	15562
there	15582
a significant difference	15592
OECs	15634
the key factor impelling the function recovery of injured spinal cord	15642
the key factor	15642
the function recovery of injured spinal cord	15667
the function recovery	15667
injured spinal cord	15692
the problem	15717
there	15736
a significant difference	15745
function recovery	15773
experimental group and control group within 1 week after transplantation	15799
experimental group and control group	15799
1 week after transplantation	15843
1 week	15843
transplantation	15856
We	15873
it	15889
the secretion of varied neurotrophic factors12 and the myelination function18	15911
the secretion	15911
varied neurotrophic factors12 and the myelination function18	15928
varied neurotrophic factors12	15928
the myelination function18	15962
OECs	15992
the functional recovery or the temporary replacement of nerve function	16010
the functional recovery	16010
the temporary replacement of nerve function	16037
the temporary replacement	16037
nerve function	16066
some neurotrophic factors	16084
The relationship between the cell number and the spinal cord function recovery	16111
The relationship	16111
the cell number and the spinal cord function recovery	16136
the cell number	16136
the spinal cord function recovery	16156
another concerned problem	16193
It	16220
the dose-effect relationship during practical usage	16240
the dose-effect relationship	16240
practical usage	16276
the formulation of clinical principle and standardization	16301
the formulation	16301
clinical principle and standardization	16320
transplantation	16362
previous studies concerning the problem	16393
previous studies	16393
the problem	16421
our experimental results	16446
a definite answer	16483
We	16502
OECs number	16521
the rats	16555
motor function recovery	16570
the late stage of transplantation	16605
the late stage	16605
transplantation	16623
This distinct experimental phenomenon	16640
the dose-effect relationship between the cell number and function recovery	16707
the dose-effect relationship	16707
the cell number and function recovery	16744
a large sample observation	16793
an exact answer	16843
the future	16862
this experiment	16877
the duration of observation	16894
the duration	16894
observation	16910
only 13 weeks after transplantation	16925
only 13 weeks	16925
transplantation	16945
It	16962
1 year or more	16990
1 year	16990
more	17000
future studies	17008
the end-result of OECs in injured spinal cord	17042
the end-result	17042
OECs in injured spinal cord	17060
OECs	17060
injured spinal cord	17068
